Infectious enteritis is associated with an increased long-term risk of developing irritable bowel syndrome, functional dyspepsia, and elevated healthcare use.
Cognitive behavioral therapy (CBT) for IBS is an effective way to target the brain-gut axis and improve symptoms, but few ...
In a new study, people with IBS who snacked more frequently had less severe symptoms. Experts explain the link and reveal ...
Relying on at-home tests alone may delay diagnosis of more serious gastrointestinal diseases. Taking an at-home test for ...
A new study traces the molecular pathway connecting the gut immune system to the brain during a parasitic infection, ...
Researchers have identified two gut bacteria that can produce serotonin, a key chemical that regulates bowel movements. In experiments with mice lacking serotonin, the microbes boosted serotonin ...
Estrogen may cause certain colon cells, shown in green in this microscope image, to release a hormone called peptide YY. This, in turn, causes a different type of colon cell, colored magenta, to pump ...
The FDA has approved linaclotide (Linzess) for children aged 7 years or older with irritable bowel syndrome with constipation (IBS-C), making it the first approved treatment for pediatric IBS-C. The ...
The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 years and older, the agency announced Wednesday. The decision makes the ...
What Is It, and Why Does It Matter? Linzess (linaclotide) is a prescription medicine that helps ease constipation caused by irritable bowel syndrome (IBS-C). It works by drawing more fluid into your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results